Adeno-Associated Virus Delivery Limitations for Neurological Indications
Benatti, Hector Ribeiro ; Gray-Edwards, Heather L
Benatti, Hector Ribeiro
Gray-Edwards, Heather L
Citations
Altmetric:
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Editorial
Publication Date
2022-01-17
Keywords
Subject Area
Collections
Embargo Expiration Date
Link to Full Text
Abstract
In this commentary we discuss pitfalls and limitations of current adeno-associated virus (AAV) delivery routes, dose scaling, and the extrapolation of animal data to first-in-human (FIH) AAV clinical trials.
Source
Benatti HR, Gray-Edwards HL. Adeno-Associated Virus Delivery Limitations for Neurological Indications. Hum Gene Ther. 2022 Jan;33(1-2):1-7. doi: 10.1089/hum.2022.29196.hrb. PMID: 35049369.
Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1089/hum.2022.29196.hrb
Permanent Link to this Item
PubMed ID
35049369